首页> 外文期刊>Oncology, Gastroenterology and Hepatology Reports >FNAC of the Thyroid Following Carbimazole Therapy in Hyperthyroidism: A Diagnostic Dilemma
【24h】

FNAC of the Thyroid Following Carbimazole Therapy in Hyperthyroidism: A Diagnostic Dilemma

机译:甲亢治疗后甲状腺的FNAC:诊断难题

获取原文
       

摘要

Antithyroid drug therapy is routinely used for treatment of hyperthyroid patients. Therapy induced changes in hyperthyroidism can cause serious diagnostic dilemma on FNAC and have been rarely documented. We present a case of 45-year-old female patient who clinically presented with diffuse thyroid swelling and features of hyperthyroidism. FNAC from thyroid swelling showed features of Hashimoto’s thyroiditis / Grave’s disease / Colloid goiter with follicular hyperplasia and at places raising the suspicion of malignant transformation. Further clinical evaluation of patient, it was found that she had carbimazole therapy. Correlating the clinical and cytomorphologic features, a diagnosis of “therapy induced (carbimazole) changes in hyperthyroidism was given.
机译:抗甲状腺药物疗法通常用于治疗甲亢患者。由治疗引起的甲亢改变可导致FNAC严重的诊断难题,并且鲜有文献报道。我们介绍了一例45岁女性患者,临床表现为甲状腺弥漫性肿胀和甲亢。来自甲状腺肿胀的FNAC表现出桥本氏甲状腺炎/格雷夫病/胶体甲状腺肿伴滤泡增生,并在某些地方引起恶性转化。对患者进行进一步的临床评估后,发现她接受了卡咪唑治疗。结合临床和细胞形态学特征,诊断为“治疗引起的甲氨基咪唑(carbimazole)改变”。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号